FLAVORx debuts Pill Glide at NACDS Pharmacy & Technology Conference
BOSTON For as long as medicines have come in pill form, many parents have struggled to find ways to get their reluctant kids to take them, but it’s a problem that affects adults, too, according to some polls.
At the National Association of Chain Drug Stores’ Pharmacy & Technology Conference Saturday, Columbia, Md.-based FLAVORx unveiled Pill Glide, a patent-pending flavored spray designed to ease the process of taking tablets and capsules by lubricating the inside of the mouth. The spray, which is classified as a food rather than a drug, is aimed mostly at children and the elderly, as well as patients with chronic illnesses who must take multiple medications.
“It helps overcome the physical and psychological barriers to swallowing,” FLAVORx CEO Stuart Amos told Drug Store News, adding that the company had sold 50 cases to “medium and large” retail pharmacy chains in the first three hours of the conference.
A 2004 Harris Interactive poll found that 40% of American adults had difficulty swallowing pills. Of those, 14% said they had delayed doses and 8% had skipped them altogether because they couldn’t swallow pills properly.
“The idea of Pill Glide is, it should help overcome the reluctance to swallow by easing the passage of pills and capsules,” Amos said.
Asteres to debut new automated pharmacy kiosk at NACDS Pharmacy & Technology Conference
SAN DIEGO A company that makes automated pharmacy kiosks plans to unveil its latest products at an upcoming conference.
Asteres, which makes the ScriptCenter kiosk, announced this week that it would debut ScriptCenter 24/7 Automated Pharmacy Services at the 2009 National Association of Chain Drug Stores Pharmacy & Technology Conference in Boston, which begins Saturday.
“To date, ScriptCenter has enabled retailers to reduce pharmacy hours and increase customer services,” Asteres CEO Mark de Bruin said in a statement. “The addition of 24/7 Automated Pharmacy Services will expand customer engagement opportunities and drive incremental store sales leveraging kiosk, online and cell technologies.”
The services include the Express Prescription Pickup, Prescription Drop Off Anytime, one-touch pickup for families, ScriptCenter.com and others.
Sciele Pharma announces availability of head lice treatment
NEW YORK A new drug for treating head lice has become available from a subsidiary of a Japanese drug company.
Sciele Pharma, part of Shionogi, announced this week the availability of Ulesfia (benzyl alcohol lotion 5%). The medication kills head lice by asphyxiation without potential neurotoxic side effects, the company said.
Head lice infestation affects 6 to 12 million children between the ages of 3 and 12 every year. To breathe, head lice use breathing holes that close upon contact with most liquids, which allows them to go into suspended animation and survive for hours without respiration, but Ulesfia prevents them from closing their breathing holes, causing the insects to asphyxiate.